Retraction notice to “Synthesis, carbonic anhydrase enzyme inhibition evaluations, and anticancer studies of sulfonamide based thiadiazole derivatives” [BMCL 57 (2022) 128520](S0960894X21007472)(10.1016/j.bmcl.2021.128520)

Ali Bahadur, Shahid Iqbal, Saiqa Muneer, Hashem O. Alsaab, Nasser S. Awwad, Hala A. Ibrahium

Research output: Journal PublicationComment/debate

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor. The article duplicates significant parts of a paper that had already appeared in Journal of Molecular Structure, volume 1246, 2021, 131145, https://doi.org/10.1016/j.molstruc.2021.131145. One of the conditions of submission of a paper for publication is that authors declare explicitly that the paper has not been previously published and is not under consideration for publication elsewhere. Re-use of any data should be appropriately cited. As such this article represents a misuse of the scientific publishing system. The scientific community takes a very strong view on this matter and apologies are offered to readers of the journal that this was not detected during the submission process.

Original languageEnglish
Article number128720
JournalBioorganic and Medicinal Chemistry Letters
Volume65
DOIs
Publication statusPublished - 1 Jun 2022
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Retraction notice to “Synthesis, carbonic anhydrase enzyme inhibition evaluations, and anticancer studies of sulfonamide based thiadiazole derivatives” [BMCL 57 (2022) 128520](S0960894X21007472)(10.1016/j.bmcl.2021.128520)'. Together they form a unique fingerprint.

Cite this